NASDAQ:CTRE - CareTrust REIT Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $24.29
  • Forecasted Upside: 2.64 %
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$23.66
▲ +0.44 (1.89%)

This chart shows the closing price for CTRE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New CareTrust REIT Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CTRE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CTRE

Analyst Price Target is $24.29
▲ +2.64% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for CareTrust REIT in the last 3 months. The average price target is $24.29, with a high forecast of $26.00 and a low forecast of $22.00. The average price target represents a 2.64% upside from the last price of $23.66.

This chart shows the closing price for CTRE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 8 contributing investment analysts is to buy stock in CareTrust REIT. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/31/2019
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/30/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/28/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/26/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/25/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/25/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/24/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/24/2021Royal Bank of CanadaBoost Price TargetOutperform$24.00 ➝ $26.00Low
3/5/2021Raymond JamesReiterated RatingBuy$25.00Low
1/19/2021BarclaysBoost Price TargetOverweight$21.00 ➝ $25.00Low
1/13/2021MizuhoBoost Price TargetNeutral$19.00 ➝ $22.00Low
1/7/2021BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$25.00 ➝ $26.00Medium
12/14/2020KeyCorpUpgradeSector Weight ➝ Overweight$24.00Low
12/2/2020Berenberg BankUpgradeHold ➝ BuyLow
11/11/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$20.00 ➝ $22.00Low
10/2/2020MizuhoBoost Price TargetNeutral$13.00 ➝ $19.00High
9/1/2020Stifel NicolausReiterated RatingBuy$22.00High
8/10/2020Raymond JamesBoost Price TargetStrong-Buy$21.00 ➝ $22.00Medium
8/3/2020Raymond JamesUpgradeOutperform ➝ Strong-Buy$20.00 ➝ $21.00High
6/17/2020Wells Fargo & CompanyBoost Price TargetOverweight$20.00 ➝ $21.00Low
4/29/2020Raymond JamesUpgradeMarket Perform ➝ Outperform$19.00High
4/6/2020MizuhoUpgradeUnderperform ➝ Neutral$19.00 ➝ $13.00High
3/26/2020Wells Fargo & CompanyLower Price TargetOverweight$24.00 ➝ $20.00Low
2/28/2020Berenberg BankDowngradeBuy ➝ Hold$24.00Low
1/7/2020BMO Capital MarketsDowngradeOutperform ➝ Market Perform$26.00 ➝ $22.00Medium
12/19/2019MizuhoInitiated CoverageUnderperformMedium
9/12/2019Berenberg BankInitiated CoverageBuy$29.00Medium
9/3/2019BarclaysInitiated CoverageOverweight$26.00Low
8/21/2019Capital One FinancialUpgradeEqual Weight ➝ Overweight$25.00Low
8/7/2019BMO Capital MarketsReiterated RatingBuy$26.00High
5/31/2019Raymond JamesDowngradeStrong-Buy ➝ Market Perform$25.00Medium
5/8/2019Stifel NicolausSet Price TargetBuy$26.00Low
4/9/2019BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$22.00 ➝ $25.00Medium
2/14/2019BMO Capital MarketsReiterated RatingBuy$22.00High
1/9/2019BMO Capital MarketsUpgradeMarket Perform ➝ OutperformHigh
1/8/2019Raymond JamesUpgradeOutperform ➝ Strong-BuyHigh
12/4/2018Wells Fargo & CompanyBoost Price TargetOutperform ➝ Outperform$18.50 ➝ $22.00High
11/28/2018Stifel NicolausUpgradeHold ➝ Buy$17.00 ➝ $21.00High
11/5/2018Cantor FitzgeraldReiterated RatingBuy$20.00High
10/29/2018Cantor FitzgeraldReiterated RatingBuy$20.00Medium
8/21/2018KeyCorpBoost Price TargetOverweight ➝ Buy$16.00 ➝ $20.00Low
8/9/2018Royal Bank of CanadaReiterated RatingSector Perform ➝ Hold$16.00 ➝ $18.00High
5/31/2018Wells Fargo & CompanySet Price TargetOutperform ➝ Buy$16.50 ➝ $19.00Low
5/24/2018Royal Bank of CanadaBoost Price TargetSector Perform ➝ Hold$15.00 ➝ $16.00Low
5/8/2018Cantor FitzgeraldInitiated CoverageBuy$16.00High
5/8/2018BMO Capital MarketsReiterated RatingHold$15.00High
3/27/2018BMO Capital MarketsReiterated RatingHold$15.00Low
3/6/2018Royal Bank of CanadaReiterated RatingHold$15.00Medium
3/6/2018KeyCorpSet Price TargetOverweight ➝ Buy$20.00 ➝ $16.00Low
3/5/2018Cantor FitzgeraldInitiated CoverageOverweight$16.00Low
2/28/2018Stifel NicolausSet Price TargetHold ➝ Hold$19.00 ➝ $17.00High
1/12/2018StephensSet Price TargetBuy$19.00Low
12/19/2017Wells Fargo & CompanyUpgradeMarket Perform ➝ Outperform$20.00Medium
11/9/2017BMO Capital MarketsReiterated RatingHold$20.00N/A
11/9/2017Stifel NicolausReiterated RatingHold ➝ Hold$17.00 ➝ $19.00N/A
10/29/2017KeyCorpSet Price TargetBuy$20.00N/A
10/23/2017Capital One FinancialInitiated CoverageEqual Weight$21.00N/A
10/22/2017Capital One FinancialReiterated RatingEqual Weight$21.00N/A
8/25/2017KeyCorpReiterated RatingBuy$20.00Low
6/20/2017BMO Capital MarketsDowngradeOutperform ➝ Market Perform$18.00 ➝ $20.00Low
5/17/2017Raymond JamesReiterated RatingOutperform$17.00 ➝ $19.00Low
5/15/2017BMO Capital MarketsSet Price TargetBuy$18.00Low
5/3/2017Canaccord GenuityReiterated RatingBuy$19.00Low
4/12/2017BMO Capital MarketsReiterated RatingBuy$18.00Low
3/30/2017Canaccord GenuityBoost Price TargetBuy ➝ Buy$18.00 ➝ $19.00High
3/20/2017BMO Capital MarketsReiterated RatingBuy$16.00Low
2/8/2017Canaccord GenuityReiterated RatingBuy$18.00N/A
1/3/2017Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$16.00N/A
11/22/2016JMP SecuritiesReiterated RatingHoldN/A
11/3/2016Canaccord GenuityReiterated RatingBuyN/A
11/3/2016BarclaysReiterated RatingHold$16.00N/A
10/24/2016JMP SecuritiesInitiated CoverageMarket PerformN/A
9/14/2016StephensInitiated CoverageOverweight$16.00N/A
9/8/2016Canaccord GenuityReiterated RatingBuy$18.00N/A
8/25/2016Raymond JamesInitiated CoverageOutperform$13.50N/A
8/22/2016BarclaysInitiated CoverageEqual Weight$16.00N/A
8/15/2016Canaccord GenuityReiterated RatingBuy$16.00 ➝ $18.00N/A
8/15/2016Canaccord GenuityBoost Price TargetBuy$16.00 ➝ $18.00N/A
7/26/2016Wells Fargo & CompanyReiterated RatingMarket PerformN/A
7/26/2016Wells Fargo & CompanyInitiated CoverageMarket PerformN/A
(Data available from 6/24/2016 forward)
CareTrust REIT logo
CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. With a nationwide portfolio of long-term net-leased properties, and a growing portfolio of quality operators leasing them, CareTrust REIT is pursuing both external and organic growth opportunities across the United States.
Read More

Today's Range

Now: $23.66
Low: $23.06
High: $23.67

50 Day Range

MA: $23.44
Low: $22.26
High: $24.57

52 Week Range

Now: $23.66
Low: $16.13
High: $24.89

Volume

428,097 shs

Average Volume

595,957 shs

Market Capitalization

$2.29 billion

P/E Ratio

27.51

Dividend Yield

4.57%

Beta

1.09

Frequently Asked Questions

What sell-side analysts currently cover shares of CareTrust REIT?

The following Wall Street research analysts have issued research reports on CareTrust REIT in the last twelve months: Barclays PLC, Berenberg Bank, BMO Capital Markets, KeyCorp, Mizuho, Raymond James, Royal Bank of Canada, Stifel Nicolaus, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for CTRE.

What is the current price target for CareTrust REIT?

7 Wall Street analysts have set twelve-month price targets for CareTrust REIT in the last year. Their average twelve-month price target is $24.29, suggesting a possible upside of 4.6%. BMO Capital Markets has the highest price target set, predicting CTRE will reach $26.00 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of $22.00 for CareTrust REIT in the next year.
View the latest price targets for CTRE.

What is the current consensus analyst rating for CareTrust REIT?

CareTrust REIT currently has 1 hold rating and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CTRE will outperform the market and that investors should add to their positions of CareTrust REIT.
View the latest ratings for CTRE.

What other companies compete with CareTrust REIT?

How do I contact CareTrust REIT's investor relations team?

CareTrust REIT's physical mailing address is 905 CALLE AMANECER SUITE 300, SAN CLEMENTE CA, 92673. The real estate investment trust's listed phone number is 949-542-3130 and its investor relations email address is [email protected] The official website for CareTrust REIT is www.caretrustreit.com.